PRESS RELEASE

Integromics Biomarker Discovery 2.0 for Tibco Spotfire

Tibco Software, together with Intergromics, has released Integromics Biomarker Discovery 2.0 for Tibco Spotfire, a solution for advanced methods of data access, normalisation, pattern detection, treatment comparison, and functional analysis for analysis of genomic expression data.

The scientific and workflow knowledge of Intergromics, combined with the adaptability and ease of use of the Tibco Spotfire Enterprise Analytics Platform, provides pharmaceutical, biotechnology, and academic research groups with a powerful genomic data analysis environment that quickly finds and categorises complex patterns. With interactive analysis and high-impact visualisation capabilities, Integromics Biomarker Discovery 2.0 rapidly reveals insights and unexpected relationships in genomics data. This allows researchers and scientists to examine the expression and annotation dimensions of their data and perform a variety of numerical analyses.

Company: 
Feature

Sophia Ktori highlights the role of the laboratory software in the use of medical diagnostics

Feature

Gemma Church explores the use of modelling and simulation to predict weather and climate patterns

Feature

Robert Roe reviews the latest in accelerator technology and finds that GPUs and coprocessors will be key fixtures in the future of deep learning

Feature

Robert Roe finds that commoditisation of flash and SSD technology and the uptake of machine learning and AI applications are driving new paradigms in storage technology.